Disabled-2 inactivation is an early step in ovarian tumorigenicity

Oncogene

Volumn 18, Issue 20, 1999, Pages 3104-3113

  Fazili, Zia ^a   Sun, Wenping ^a   Mittelstaedt, Stephen ^a   Cohen, Cynthia ^a   Xu, Xiang Xi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Disabled 2 (Dab2); Expression; Immunohistology; Ovarian cancer

Indexed keywords

ANIMAL TISSUE; ARTICLE; BREAST CANCER; CARCINOGENICITY; EPITHELIUM CELL; EPITHELIUM TUMOR; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; MOUSE; NONHUMAN; OVARY CANCER; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; AMINO ACID SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; OVARY; PHOSPHOPROTEINS; PROTEINS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0033587017     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202649     Document Type: Article

References (37)

1. Albertsen HM, Smith SA, Melis R, William B, Holik P, Stevens J and White R. (1996). Genomics, 33, 207-213.
2. Bast Jr RC, Boyer CM, Jacobs I, Xu FJ, Wu S, Wiener J, Kohler M and Berchuck A. (1993). Cancer, 15, 1597-1601.
3. Bell DA. (1991). Human Path., 22, 750-762.
4. Berchuck A and Carney M. (1997). Biochem. Pharmacol., 54, 541-544.
5. Bork P and Margolis B. (1995). Cell, 80, 693-694.
6. Bos JL. (1989). Cancer Res., 49, 4682-4689.
7. Buday L, Warne PH and Downward J. (1995). Oncogene, 11, 1327-1331.
8. Cherniack AD, Klarlund JK, Conway BR and Czech MP. (1995). J. Biol. Chem., 270, 1485-1488.
9. Clark GJ and Der CJ. (1995). Breast Cancer Res. Treat., 35, 133-144.
10. D'Arcangelo G, Nakajima K, Miyata T, Ogawa M, Mikoshiba K and Curran T. (1997). J. Neurosci., 17, 23-31.
11. Fazili Z, Sun W, Mittelstaedt S, Cohen C, Mendez LE, Horowitz IR and Xu XX. (1998). Disabled-2 gene inactivation by homozygous deletion in breast and ovarian tumors. (submitted).
12. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K; Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, et al. (1994). Science, 266, 120-122.
13. Gertler FB, Bennett RL, Clark ML and Hoffmann FM. (1989). Cell, 58, 103-113.
14. Gertler FB, Hill KH, Clark ML and Hoffmann FM. (1993). Genes & Develop., 7, 441-453.
15. Godwin AK, Testa JR and Hamilton TC. (1993). Cancer, 71, 530-536.
16. Hoffmann FM. (1991). Trends Genet., 7, 351-355.
17. Howell BW, Gertler FB and Cooper JA. (1997a). EMBO J., 16, 121-132.
18. Howell BW, Hawkes R, Soriano P and Cooper JA. (1997b). Nature, 389, 733-737.
19. Kavanaugh VM and Williams LT. (1994). Science, 266, 1862-1865.
20. Knudson AG. (1993). Proc. Natl. Acad. Sci. USA. 90, 10914-10921.
21. Lim WA, Richards FM and Fox RO. (1994). Nature, 372, 375-379.
22. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. (1994). Science, 266, 66-71.
23. Mok SC, Wong KK, Chan RK, Lau CC, Tsao SW, Knapp RC and Berkowitz RS. (1994). Gynecol. Oncol., 52, 247-252.
24. Mok SC, Chan WY, Wong KK, Cheung KK, Lau CC, Ng SW, Baldini CV, Rock CO and Berkowitz RS. (1998). Oncogene, 16, 2381-2387.
25. Ren R, Mayer BJ, Cicchetti P and Baltimore D. (1993). Science, 259, 1157-1161.
26. Sheldon M, Rice DS, D'Arcangelo G, Yoneshima H, Nakajima K, Mikoshiba K, Howell BW, Cooper JA, Goldowitz D and Curran T. (1997). Nature, 389, 730-733.
27. Stenback F and Wasenius VM. (1985). Eur. J. Obstet. Gynecol. Reprod. Biol., 20, 357-371.
28. Szabo CI and King MC. (1995). Hum. Mol. Genet., 4, 1811-1817.
29. Ware ML, Fox JW, Gonzalez JL, Davis NM, Lambert de Rouvroit C, Russo CJ, Chua Jr SC and Goffinet AM. (1997). Neuron, 19, 239-249.
30. Waters SB, Yammauchi K and Pessin J. (1995). Mol. Cell. Biol., 15, 2791-2799.
31. Wingo PA, Tong T and Bolden S. (1995). CA Cancer J. Clin., 45, 8-30.
32. Wittekind M, Mapelli C, Farmer II BF, Suen KL, Goldfarb V, Tsao J, Lavoie T, Barbacid M, Meyers CA and Mueller L. (1994). Biochem., 33, 13531-13539.
33. Wong KK, Mok CH, Welsh J, McClelland M, Tsao SW and Berkowitz RS. (1993). Intern. J. Oncol., 3, 13-17.
34. Xu XX, Yang W, Jackowski S and Rock CO. (1995). J. Biol. Chem., 270, 14184-14191.
35. Xu XX, Yi T, Tang B and Lambeth JD. (1998). Oncogene, 16, 1561-1569.
36. Zheng J, Benedict WF, Xu HJ, Hu SX, Kim TM, Velicescu M, Wan M, Cofer KF and Dubeau L. (1995). J. Natl. Cancer Inst., 15, 1146-1153.
37. Zhou DJ, Gonzalez-Cadavid N, Ahuja H, Battifora H, Moore GE and Cline MJ. (1988). Cancer, 62, 1573-1576.